Verrata
Total Payments
$2.1M
Transactions
121
Doctors
83
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2018 | $4,646 | 64 | 44 |
| 2017 | $2.1M | 57 | 39 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $2.1M | 4 | 99.6% |
| Food and Beverage | $4,506 | 114 | 0.2% |
| Consulting Fee | $3,900 | 2 | 0.2% |
| Travel and Lodging | $34.00 | 1 | 0.0% |
Payments by Type
Research
$2.1M
4 transactions
General
$8,440
117 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| Safe Stemi | Philips Electronics North America Corporation | $2.1M | 0 |
| iFRFFR in TAVR | Philips Electronics North America Corporation | $1,940 | 0 |
| ISCHEMIA 2 | Philips Electronics North America Corporation | $776.00 | 0 |
Top Doctors Receiving Payments for Verrata — Page 4
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| , MD | Cardiovascular Disease | Chattanooga, TN | $11.50 | 1 |
| , M.D | Internal Medicine | Winchester, VA | $10.96 | 1 |
| , MD | Internal Medicine | Burr Ridge, IL | $10.94 | 1 |
| , MD | Interventional Cardiology | Chicago, IL | $10.93 | 1 |
| , M.D | Cardiovascular Disease | Chicago, IL | $10.93 | 1 |
| Rohan Kalathiya | Interventional Cardiology | Chicago, IL | $10.93 | 1 |
| , M.D | Internal Medicine | Chicago, IL | $10.93 | 1 |
| , DO | Cardiovascular Disease | Kankakee, IL | $6.70 | 1 |
| , MD | Cardiovascular Disease | Saint Louis, MO | $3.61 | 1 |
Ad
Manufacturing Companies
Product Information
- Type Device
- Total Payments $2.1M
- Total Doctors 83
- Transactions 121
About Verrata
Verrata is a device associated with $2.1M in payments to 83 healthcare providers, recorded across 121 transactions in the CMS Open Payments database. The primary manufacturer is Philips Electronics North America Corporation.
Payment data is available from 2017 to 2018. In 2018, $4,646 was paid across 64 transactions to 44 doctors.
The most common payment nature for Verrata is "Unspecified" ($2.1M, 99.6% of total).
Verrata is associated with 3 research studies, including "Safe Stemi" ($2.1M).